中华肝胆外科杂志
中華肝膽外科雜誌
중화간담외과잡지
CHINESE JOURNAL OF HEPATOBILIARY SURGERY
2015年
3期
206-209
,共4页
曲凤智%王刚%孙备%姜洪池
麯鳳智%王剛%孫備%薑洪池
곡봉지%왕강%손비%강홍지
新辅助治疗%临界可切除胰腺癌%R0切除
新輔助治療%臨界可切除胰腺癌%R0切除
신보조치료%림계가절제이선암%R0절제
Neoadjuvant therapy%Borderline resectable pancreatic cancer (BRPC)%R0 resection
临界可切除胰腺癌(BRPC)是介于可切除和不可切除胰腺癌之间的一种特殊类型,手术切除率低,术后复发率高.目前,对BRPC进行新辅助治疗使其转化为可切除的胰腺癌已成为胰腺癌领域的研究热点.新辅助治疗在显著提高BRPC的R0切除率及延长胰腺癌患者整体中位生存期中发挥了重要的作用.但至今未见其规范化的治疗方案出台.本文对BRPC新辅助治疗的研究进展做一综述.
臨界可切除胰腺癌(BRPC)是介于可切除和不可切除胰腺癌之間的一種特殊類型,手術切除率低,術後複髮率高.目前,對BRPC進行新輔助治療使其轉化為可切除的胰腺癌已成為胰腺癌領域的研究熱點.新輔助治療在顯著提高BRPC的R0切除率及延長胰腺癌患者整體中位生存期中髮揮瞭重要的作用.但至今未見其規範化的治療方案齣檯.本文對BRPC新輔助治療的研究進展做一綜述.
림계가절제이선암(BRPC)시개우가절제화불가절제이선암지간적일충특수류형,수술절제솔저,술후복발솔고.목전,대BRPC진행신보조치료사기전화위가절제적이선암이성위이선암영역적연구열점.신보조치료재현저제고BRPC적R0절제솔급연장이선암환자정체중위생존기중발휘료중요적작용.단지금미견기규범화적치료방안출태.본문대BRPC신보조치료적연구진전주일종술.
Borderline resectable pancreatic cancer (BRPC),characterized by low resectability rate and high postoperative recurrence rate,is a special kind of pancreatic cancer between resectable type and nonresectable one.Currently,the efficacy of neoadjuvant therapy for BRPC has become a hot topic in the field of pancreatic cancer.Although neoadjuvant therapy plays a critical role in obviously improving the R0 resectability rate and survival status of BRPC patients,the normalized therapeutic regimen has not been established.In this article,we overviewed the recent progress on the neoadjuvant therapy in treating BRPC.